Corticosteroids, Pregnancy, and HELLP Syndrome: A Review
Authors:
- P J. van Runnard HeimelPHP J. van Runnard Heimel
- A FranxAFA Franx
- A F.A.M. SchobbenASA F.A.M. Schobben
- A J.M. HuisjesAHA J.M. Huisjes
- J B. DerksJDJ B. Derks
- H W. BruinseHBH W. Bruinse
- 1 January 2005
- journal article
- review article
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 60 (1) , 57-70
Abstract
Corticosteroids are potent antiinflammatory and immunosuppressive drugs, which are used in the treatment of a wide range of medical disorders. During pregnancy, several corticosteroids are administered for maternal as well as fetal reasons. Prednisone and prednisolone show limited transplacental passage and are thus used for treatment of maternal disease. Dexamethasone and betamethasone, drugs that can easily cross the placenta, are more suitable for fetal indications. During the last decade, administration of corticosteroids was introduced in the treatment of hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome), a severe form of preeclampsia unique to human pregnancy. Several randomized, controlled trials as well as other prospective and retrospective studies have been performed to investigate this beneficial effect of corticosteroids on biochemical measures and clinical signs. This review discusses the characteristics of corticosteroids in humans and details the use of corticosteroids during pregnancy. A review of literature on the effect of corticosteroids on HELLP syndrome is given and possible mechanisms of action are discussed. Obstetricians & Gynecologists, Family Physicians After completion of this article, the reader should be able to compare the relative strength of the commercially available steroids, to outline the pharmacologic characteristics of glucocorticoids in humans, to compare the anti-inflammatory characteristics of corticosteroids, to explain the changes in glucocorticoid metabolism during pregnancy, and to list the effects of corticosteroids on the fetus.Keywords
This publication has 156 references indexed in Scilit:
- Choice and dose of corticosteroid for antenatal treatmentsAmerican Journal of Obstetrics and Gynecology, 2004
- Repeat courses of antenatal corticosteroids: The controversy continuesAmerican Journal of Obstetrics and Gynecology, 2004
- The fetal cardiovascular response to antenatal steroids in severe early-onset intrauterine growth restrictionAmerican Journal of Obstetrics and Gynecology, 2004
- Dexamethasone compared with betamethasone for glucocorticoid treatment of postpartum HELLP syndromeInternational Journal of Gynecology & Obstetrics, 2003
- CRITICAL CARE OF HELLP SYNDROME WITH CORTICOSTEROIDSAmerican Journal of Perinatology, 2000
- Impact of high-dose corticosteroid therapy for patients with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndromeAmerican Journal of Obstetrics and Gynecology, 2000
- Dexamethasone in the post‐partum treatment of HELLP syndromeInternational Journal of Gynecology & Obstetrics, 1997
- Effects of immunosuppressive drugs during pregnancyArthritis & Rheumatism, 1995
- Transport and metabolism of dexamethasone in the dually perfused human placentaReproductive Toxicology, 1988
- The transplacental passage of prednisone and prednisolone in pregnancy near termThe Journal of Pediatrics, 1972